Understanding Immunity and Anti-aging Advancements through Mikhail Blagosklonny

The possibility of immunity enhancement in humans as shown by 2014 studies caused a celebration in the science world as this was considered a breakthrough in the research on human immortality. This was the turning point that was made as a prediction back in the days about ten years ago. The cause of human death especially when aging is eliminated.

The belief that aging was as a result of the functional decline in the accumulation of random molecular damage stood the test of time until recently. This belief has only been broken because of the theory that explains aging as a growth continuation process that signals unique pathways including TOR. This centric model makes the prediction of how rapamycin can be effectively used in the treatment of aging and preventing diseases. This way people get to grow older and healthier thus prolonging lives and delaying death. Research has shown that Rapamycin and other related drugs can help extend human life as long as they are administered in appropriate dosages as well as schedules. Visit ResearchGate to keep up to date with Mikhail’s latest work.

Mikhail Blagosklonny is known to have made major contributions towards the development of cancer treatment as well as participated in the advancement of anti-aging solutions. Being a professor of Oncology, Mikhail explains the phenomenon surrounding aging as he is well known for conducting significant studies around this subject and cancer cures. Mikhail is a Professor at the Roswell Cancer Center. He attended the Pavlov State Medical University of St Petersburg where he attained an MD in Internal Medicine. He also earned his Ph.D. in Experimental Medicine. He served as a senior scientist at Ordway research institute. Mikhail became great at research work due to the experience he continually gained at the different places he worked.

Mikhail also works as the Chief Editor of Oncotarget as well as the Cell Cycle. Additionally, he serves as an associate editor for the Cancer and Biology Therapy. He also serves on Cell Division and Differentiation board of editors. He developed a hypothesis based on TOR signaling as he researched on its role for cancer treatment and in aid of anti-aging process. He is the one who made the proposal on the use of Rapamycin, which is a popular drug in the treatment of cancer as well as in the longevity research.

Professor Mikhail handles research that ranges from molecular biology, cellular biology as well as clinical investigations. This includes mainly focus on areas such as ontogenesis, apoptosis, anti-cancer therapeutics, mitosis, tumor suppressors as well as signal transduction. Mikhail has authored the hyperactive function theory. He has also been instrumental in the writing of chemotherapeutic engineering as well as the cell cyclotherapy.

Dr. Mikhail Blaglosklonny has a strong belief that cancer and aging are matters that can be controlled. He also believes in the cure of cancer, which explains his proposal of rapamycin as a potential treatment, and people do not have to die because of something that can be controlled. It is these research findings that have helped propel him to succeed in his career. View Mikhail’s profile on Google Scholar

Leave a Reply

Your email address will not be published. Required fields are marked *